← Product Code [KPI](/submissions/GU/subpart-f%E2%80%94therapeutic-devices/KPI) · K973096 # NEOTONUS MODEL 1000 MUSCLE STIMULATOR SYSTEM (K973096) _Neotonus, Inc. · KPI · Jun 12, 1998 · Gastroenterology, Urology · SESE_ **Canonical URL:** https://fda.innolitics.com/submissions/GU/subpart-f%E2%80%94therapeutic-devices/KPI/K973096 ## Device Facts - **Applicant:** Neotonus, Inc. - **Product Code:** [KPI](/submissions/GU/subpart-f%E2%80%94therapeutic-devices/KPI.md) - **Decision Date:** Jun 12, 1998 - **Decision:** SESE - **Submission Type:** Traditional - **Regulation:** 21 CFR 876.5320 - **Device Class:** Class 2 - **Review Panel:** Gastroenterology, Urology - **Attributes:** Therapeutic ## Indications for Use The NEOTONUS Model 1000 Muscle Stimulator System is intended to provide entirely non-invasive electromagnetic stimulation of pelvic floor musculature for the purpose of rehabilitation of weak pelvic muscles and restoration of neuromuscular control for the treatment of urinary incontinence in women. ## Device Story System comprises stimulator control unit and treatment chair; utilizes electromagnetic coil beneath seat to induce electric field in pelvic floor tissue. Physician/clinician-operated; patient sits fully clothed on chair. Control unit allows adjustment of pulse frequency (1-55 Hz), amplitude (0-100%), and duty/rest cycles. Induces pelvic floor muscle contraction non-invasively; eliminates need for internal electrode probes. Used for rehabilitation of weak pelvic muscles and restoration of neuromuscular control to treat urinary incontinence. Provides non-invasive alternative to traditional electrical stimulation; reported as more comfortable by patients. ## Clinical Evidence Clinical evaluation of 10 females comparing subject device to electrical stimulator. Measured EMG activity of urethral sphincter and urethral pressure. Results: Urethral pressures unaffected by either method; sphincter muscle contractions visual and palpable for both. Magnetic stimulation produced larger magnitude sphincter activity than electrical stimulation. Most patients preferred magnetic stimulation for comfort. ## Technological Characteristics Non-implanted electromagnetic muscle stimulator. Components: stimulator control unit, treatment chair with integrated 'E' shaped magnetic coil. Energy source: electrical voltage signal to coil. Adjustable parameters: pulse frequency (1-55 Hz), amplitude (0-100%), duty cycle (1-30 sec), rest period (0-60 sec). Non-invasive delivery. ## Regulatory Identification A nonimplanted electrical continence device is a device that consists of a pair of electrodes on a plug or a pessary that are connected by an electrical cable to a battery-powered pulse source. The plug or pessary is inserted into the rectum or into the vagina and used to stimulate the muscles of the pelvic floor to maintain urinary or fecal continence. When necessary, the plug or pessary may be removed by the user. This device excludes an AC-powered nonimplanted electrical continence device and the powered vaginal muscle stimulator for therapeutic use (§ 884.5940). ## Predicate Devices - InCare Pelvic Floor Therapy System ([K961872](/device/K961872.md)) - Hollister Microgyn Plus Stimulation Device ([K963222](/device/K963222.md)) - Utah Medical Liberty System ([K960496](/device/K960496.md)) - Minnova Pelvic Floor Stimulation System ([K970307](/device/K970307.md)) ## Submission Summary (Full Text) > This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com. > > Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/). {0}------------------------------------------------ K 973090 1 of 2 # 510(k) Summary ## -- Neotonus, Inc. Model 1000 Muscle Stimulator System ### Sponsor 1. Neotonus, Inc. 810-A Franklin Court Marietta, GA 30067 Contact Person: Tony J. Morris President May 28, 1998 Date Prepared: #### Device Name 2. | Proprietary Name: | NEOTONUS Model 1000 Muscle Stimulator System | |----------------------|----------------------------------------------| | Common/Usual Name: | Pelvic floor stimulator | | Classification Name: | Nonimplanted electrical continence device | #### 3. Intended Use The NEOTONUS Model 1000 Muscle Stimulator System is intended to provide entirely non-invasive electromagnetic stimulation of pelvic floor musculature for the purpose of rehabilitation of weak pelvic muscles and restoration of neuromuscular control for the treatment of urinary incontinence in women. #### Device Description 4. The Model 1000 Muscle Stimulator System consists of a stimulator control unit and a treatment chair. The stimulator control unit is used to generate a voltage signal that periodically charges an "E" shaped magnetic coil located beneath the seat of the treatment chair. Controls are available to vary the pulse frequency (1-55 Hz), pulse amplitude (0-100%), on-cycle "Duty" period (1-30 sec) and off-cycle "Rest" period (0-60 sec). During treatment, the patient sits on the treatment chair with the pelvic floor area centered over the magnetic coil. The magnetic field emitted by the coil induces an electric field in the target tissue that causes contraction of the pelvic floor musculature. The patient is treated fully clothed and there is no need for an invasive electrode probe. Treatment is suggested as up to 30 minutes per sessions separated by at least 2 days. {1}------------------------------------------------ K973096 2012 #### Basis For Substantial Equivalence 5. The Model 1000 Muscle Stimulator System is substantially equivalent to electrical stimulators used for the treatment of incontinence, including the InCare Pelvic Floor Therapy System (K961872), the Hollister Microgyn Plus Stimulation Device (K963222), the Utah Medical Liberty System (K960496), and the Minnova Pelvic Floor Stimulation System (K970307). A clinical evaluation was conducted to compare the physiological effect of the Model 1000 to that of an electrical stimulator. Ten females received treatment with both the Model 1000 and an electrical stimulator. Treatment parameters were similar for both devices. Response was measured by evaluating the EMG activity of the urethral sphincter muscle and the pressure in the urethra during stimulation. Urethral pressures were not affected by either magnetic or electrical stimulation. Muscle contractions in the urethral sphincter were visual and palpable for both types of stimulation. In all cases, the magnitude of the sphincter muscle activity produced by the magnetic stimulation was larger than that produced by the electrical stimulation. Most patients preferred the magnetic stimulation as more comfortable than the electrical stimulation. The results of this study support the substantial equivalence of the NEOTONUS Model 1000 Muscle Stimulator System to electrical stimulators for the treatment of urinary incontinence. {2}------------------------------------------------ Image /page/2/Picture/0 description: The image shows a partial document with a logo and a date. The logo on the left is for the Department of Health & Human Services. The date "JUN 12 1998" is printed below the logo, indicating the document was likely created or issued on that date. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 Neotonus, Inc. c/o Mr. James R. Veale Vice President, Regulatory Services Medical Device Consultants, Inc. 49 Plain Street North Attleboro, MA 02760 Re: K973096 Neotonus Model 1000 Muscle Stimulator System Dated: May 28, 1998 Received: May 29, 1998 Regulatory Class: II 21 CFR 876.5320/Procode: 78 KPI Dear Mr. Veale: We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the Current Good Manufacturing Practice requirements, as set forth in the Quality System Regulation (OS) for Medical Devices: General regulation (2) CFR Part 820) and that, through periodic QS inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations. This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4613. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address "http://www.fda.gov/cdrf/dsmaldsmamain.html". Sincerely vours. Lillian Yin, Ph.D Director, Division of Reproductive, Abdominal, Ear, Nose and Throat and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {3}------------------------------------------------ ### 510(k) Number (if known): K973096 Device Name: NEOTONUS MODEL 1000 MUSCLE STIMULATOR SYSTEM Indications For Usc: The NEOTONUS Model 1000 Muscle Stimulator System is intended to provide entirely noninvasive electromagnetic stimulation of pelvic floor musculature for the purpose of rehabilitation of weak pelvic muscles and restoration of neuromuscular control for the treatment of urinary incontinence in women. (PLEASE DO NOT WRITE BISLOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NECESSARY) of CDRH, Office of Dovice Evaluation (ODE) Prescription Use_ L (Per 21 CFR 801.109) OR Over-the-Counter Use_______ Robert Sattler/ (Division Sign-Off) Division of Reproductive, Abdominal, ENT, and Radiological Devic 510(k) Number (Üptional Format 1-2-96) --- **Source:** [https://fda.innolitics.com/submissions/GU/subpart-f%E2%80%94therapeutic-devices/KPI/K973096](https://fda.innolitics.com/submissions/GU/subpart-f%E2%80%94therapeutic-devices/KPI/K973096) **Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact). **Cite:** Innolitics at https://innolitics.com